Narrow your search

Library

KU Leuven (8)

ULiège (7)

FARO (5)

LUCA School of Arts (5)

Odisee (5)

Thomas More Kempen (5)

Thomas More Mechelen (5)

UCLL (5)

VIVES (5)

Vlaams Parlement (5)

More...

Resource type

book (19)


Language

English (17)

French (2)


Year
From To Submit

2022 (3)

2021 (8)

2018 (2)

2006 (1)

2000 (1)

More...
Listing 1 - 10 of 19 << page
of 2
>>
Sort by

Book
Herpes simplex virus
Author:
ISBN: 3540195491 1447116852 1447116836 Year: 1989 Volume: vol 5 Publisher: London New York Paris Springer

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Vaccin contre l'herpès simplex : l'échec du vaccin prohylactique, une aubaine pour le vaccin thérapeutique
Authors: --- ---
Year: 2018 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Le virus de l’herpès simplex, que ce soit le simplex 1 (HSV- 1) ou le simplex 2 (HSV-2) est véritablement un fléau mondial. On estimait, en 2012, que 67% de la population internationale infectée par le HSV-1 et que 417 millions de personnes portaient le HSV-2. Ces virus sont responsables dans la plupart des cas de lésions désagréables au niveau du visage et des parties génitales, mais dans certains cas provoquent des complications graves telles qu'une encéphalite ou méningite et un herpès néonatal parfois pour le nourrisson. Les traitements actuels sontmais consistent seulement à atténuer les symptômes lors d'une primo-infection ou récurrence. C'est pourquoi les firmes pharmaceutiques sont à la recherche d’une recherche s’est concentrée en premier sur l'approche prophylactique, mais les résultats des études très décevants. Suite à ces résultats, les firmes pharmaceutiques se focalisent aujourd'hui sur un vaccin thérapeutique afin de diminuer la sévérité et la fréquence des épisodes de et excrétions virales. Nous allons découvrir quelles ont été les raisons possibles de l'échec du vaccin prophylactique, l'avancement de la recherche etdéveloppement vaccin thérapeutique pour finalement tenter de répondre à la question suivante : le vaccin thérapeutique pourrait-il son épingle du jeu ? The virus herpes simplex 1 (HSV-1) or simplex 2 (HSV-2) are a worldwide scourge. In 2012, it was estimated that 67% of the international population was infected by HSV-1 and 417 million people were living with HSV-2. In general, those viruses are responsible for unpleasant facials and genitals lesions. In some cases, they cause serious complications such as encephalitis or meningitis and neonatal herpes, which can be fatal for the new born. The current treatments are effective but they only attenuate the symptoms during a primary infection or viral recurrence. It is why pharmaceutical companies are looking for a vaccine. The research primarily focused on the prophylactic approach but the results of the studies were very disappointing. Following these results, pharmaceutical companies are now focusing on a therapeutic vaccine to reduce the severity and frequency of recurrence episodes and viral shedding. We will discover which are the possible reasons for the failure of the prophylactic vaccine and the advancement of research and development of the therapeutic vaccine. We will try to finally answer the following question: the therapeutic vaccine will be able to emerge?


Book
Herpes simplex and pseudorabies viruses
Author:
Year: 1969 Publisher: Wien : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Herpes simplex virus : Pathogenesis, immunobiology and control
Author:
ISBN: 3540550666 3642772498 3642772471 Year: 1992 Volume: vol 179 Publisher: Berlin : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Prevalence of Herpes Simplex Virus Type 1 and Type 2 in persons aged 14-49 : United States, 2015-2016
Authors: ---
Year: 2018 Publisher: Hyattsville, MD : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
L'herpès génital : son diagnostic différentiel
Authors: ---
Year: 2000 Publisher: Bruxelles : Pfizer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Herpetic eye diseases : proceedings of the international symposium at the Katholieke Universiteit Leuven
Authors: --- --- ---
ISBN: 906193527X 9401089353 9400955189 Year: 1985 Volume: vol 44 Publisher: Dordrecht Boston Lancaster : W. Junk,


Book
Genital Herpes
Author:
ISBN: 128220131X 9786612201318 1435840135 Year: 2006 Publisher: [Place of publication not identified] Rosen Publishing Group Incorporated The


Book
A Meeting of Minds: In Recognition of the Contributions of Randall J. Cohrs
Authors: --- ---
ISBN: 303655260X 3036552596 Year: 2022 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

A Special Issue in memory of Randall J. Cohrs, Ph.D. Topics include original research reports on a variety of viruses as well as reviews and commentaries on Randy’s contributions to many investigations.

Keywords

Research & information: general --- Biology, life sciences --- varicella-zoster virus --- Oka strain --- human herpesvirus 6 --- human herpesvirus 7 --- corticosteroids --- serious adverse event --- herpes zoster --- IL-6 --- IL-10 --- innate immunity --- VLT --- VLT-ORF63 --- CRISPR/Cas9 --- BAC mutagenesis --- flavivirus --- SARS-CoV-2 --- pandemic preparedness --- host–virus interactions --- prion --- vaccines --- interferon lambda --- virus --- herpes simplex virus type 1 --- herpes simplex virus type 2 --- neonatal herpesvirus infection --- HSV UL6 --- herpesvirus encephalitis --- herpesvirus hepatitis --- acyclovir --- HerpeSelect test --- viral sequencing --- HELLP syndrome --- lipids --- dengue virus --- acyl-CoA --- acyl-CoA thioesterase --- fatty acids --- membranes --- rheostat --- fatty acyl-CoA --- Marek’s disease virus --- live-cell genome visualization --- lytic replication --- T cells --- latency --- genome integration --- TetO/TetR system --- varicella zoster virus --- reactivation --- genome cleavage --- AAV --- antiviral therapies --- HSV-1 --- cornea --- trigeminal ganglia --- interferon-γ --- interferon stimulatory genes --- TRIM21 --- HSV --- EBV --- KSHV --- MHV68 --- PIC --- transcription --- productive elongation --- mRNA --- rRNA --- tRNA --- herpes --- viral reactivation --- spaceflight --- dermatitis --- stress --- immune depression --- antiviral drugs --- bacterial artificial chromosome --- luciferase --- bioluminescence imaging --- skin organ culture --- humanized mice --- β-Coronavirus --- mouse hepatitis virus-A59/MHV-A59 --- mouse hepatitis virus-2/MHV2 spike protein --- fusion peptide/FP --- cell-to-cell fusion (fusogenicity) --- neuropathogenesis --- hepatitis --- demyelination --- structural rigidity --- simian varicella virus --- herpesvirus --- varicella --- VZV --- neuro-attenuated --- ORF7 --- vaccine --- n/a --- antiviral --- COVID-19 --- drug discovery --- coronavirus --- spike protein --- Mpro --- RdRp --- PLpro --- skin --- epidermis --- keratinocytes --- epidermal differentiation --- cutaneous blistering lesions --- keratins --- autophagy --- immunity --- human neuron culture --- non-coding RNA --- CD8 T cell --- T-cell epitope --- NK cell --- KIR3DL1 --- HLA-B*57:01 --- herpes simplex virus --- zoster --- skin pathogenesis --- HSV-2 --- neurons --- cell culture --- varicella-zoster --- gene expression --- ganglion --- autopsy --- saliva --- salivary VZV DNA --- dengue viruses --- Aedes aegypti --- adaptive mutation --- host-virus interactions --- Marek's disease virus


Book
Echinoderms Metabolites: Structure, Functions and Biomedical Perspectives
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

The materials published in the Special Issue reflect the real diversity of echinoderm metabolites and cover most of their specific classes and biomedical potential as antioxidant, antiviral, anticancer, and even anticoagulant preparations. The metabolites include sea urchin naphtoquinoid pigments and their semi-synthetic derivatives, sea cucumber triterpene glycosides, esters of polyhydroxysteroids from starfish, sea urchins free sterols, and sea cucumber fucosylated chondroitin sulfates. This Special Issue, “Echinoderm Metabolites: Structure, Functions, and Biomedical Perspectives”, is a collection of articles about different scientific aspects concerning low molecular weight and biopolymer metabolites from echinoderms, including their isolation and chemical structures, biological activities, biosynthesis and evolution, biological functions, and obtaining of semi-synthetic derivatives of biologically active natural products. This Special Issue includes materials about sea urchin naphtoquinoid pigments and their semi-synthetic derivatives, sea cucumber triterpene glycosides, esters of polyhydroxysteroids from starfish, sea urchin free sterols, and sea cucumber fucosylated chondroitin sulfates.

Listing 1 - 10 of 19 << page
of 2
>>
Sort by